Clinical trials
Phase 3 Prostatic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 13 |
| Active, not recruiting | 11 |
| Unknown status | 6 |
| Terminated | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Pfizer | 5 |
| Janssen Research & Development, LLC | 4 |
| Merck Sharp & Dohme LLC | 4 |
| HTA Co., Ltd. | 3 |
| Novartis Pharmaceuticals | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Aragon Pharmaceuticals, Inc. | 2 |
| Bayer | 2 |
| Ferring Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 59 |
| Neoplasm Metastasis | 3 |
| Bulbo-Spinal Atrophy, X-Linked | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Colonic Neoplasms | 1 |
| Disease | 1 |
| Emergence Delirium | 1 |
| Lung Neoplasms | 1 |
| Postoperative Cognitive Complications | 1 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.